Literature DB >> 31690336

Correction to: Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer.

Yuyuan Yao1, Qinglong Guo1, Yue Cao1, Yangmin Qiu1, Renxiang Tan2, Zhou Yu1, Yuxin Zhou1, Na Lu3.   

Abstract

In the original publication of this article [1], Fig. 3 is wrong, but does not affect discussions and conclusions drawn in the article.

Entities:  

Year:  2019        PMID： 31690336      PMCID： PMC6829918          DOI： 10.1186/s13046-019-1441-3

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN： 0392-9078


Correction to: J Exp Clin Cancer Res (2018) 37: 282 https://doi.org/10.1186/s13046-018-0960-7 In the original publication of this article [1], Fig. 3 is wrong, but does not affect discussions and conclusions drawn in the article. The corrected Fig. 3 is shown below:
Fig. 3

.

.
  1 in total

1.  Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer.

Authors:  Yuyuan Yao; Qinglong Guo; Yue Cao; Yangmin Qiu; Renxiang Tan; Zhou Yu; Yuxin Zhou; Na Lu
Journal:  J Exp Clin Cancer Res       Date:  2018-11-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.